CircTET1 inhibited RB progression by sponging miR-492/miR-494-3p and inactivating the Wnt/beta-catenin pathway, which provided new insights for RB treatment.
CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/beta-catenin Signaling Pathway.